Monitoring HIV treatment in developing countries
- PMID: 16528087
- PMCID: PMC1397781
- DOI: 10.1136/bmj.332.7541.602
Monitoring HIV treatment in developing countries
Abstract
Laboratory monitoring of antiretroviral therapy helps limit resistance but is currently not feasible in developing countries. Alternative short term approaches are needed
Figures
References
-
- Detels RMA, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280: 1497-503. - PubMed
-
- CASCADE (Concerted Action on Seroconversion to AIDS and Death in Europe) Collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection. Lancet 2000;355: 1158-9. - PubMed
-
- World Health Organization. “3×5” progress report. Geneva: WHO, 2004.
-
- World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public heath approach. Geneva: WHO, 2004. www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf (accessed 13 Feb 2005).
-
- Behforouz HL, Farmer PE, Mukherjee JS. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis 2004;38(suppl 5): S429-36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical